Yuyang Zhang

Ms. Yuyang Zhang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2025 in Materials
Verified
Journal Article
Open access
PDF file
LLLong Li
Long Li
CLCheng Lugano
Cheng Lugano
YDYuhan Du
Yuhan Du
YZYuyang Zhang
Yuyang Zhang
ZWZetao Wang
Zetao Wang
Wei ZhangWei Zhang
Wei Zhang
Steroid-induced osteonecrosis of the femoral head (SONFH) is a common and refractory orthopedic disorder, often resulting from prolonged or high-dose glucocorticoid use that impairs bone repair and vascularization. The critical impact of exosomes derived from bone mesenchymal stem cells (BMSCs) in bone regeneration has drawn increasing attention. In this study, we developed a novel type of exosomes derived from Magnesium-preconditioned BMSCs (Mg-Exos) and evaluated their therapeutic potential. In vitro experiments demonstrated that Mg-Exos effectively counteracted Dex-induced impairment in the angiogenic function of human umbilical vein endothelial cells (HUVECs) and the osteogenic differentiation of BMSCs. These findings highlight the promise of Mg-Exos as a potential cell-free therapeutic strategy for SONFH, acting through the concurrent enhancement of vascularization and bone formation. Consequently, this work lays a solid foundation for the future application of Mg-Exos in treating SONFH.

22 November 2025 in Polymers
Verified
Journal Article
Open access
PDF file
LLLong Li
Long Li
AGAlong Guo
Along Guo
YNYangyi Nie
Yangyi Nie
ZXZili Xu
Zili Xu
JDJunjie Deng
Junjie Deng
YZYuanchi Zhang
Yuanchi Zhang
Bone defect repair presents a significant clinical challenge, especially for critical-sized defects, due to the limitation of conventional 3D-printed scaffolds to provide simultaneous mechanical support and bioactivity. Herein, this study developed a bioactive composite scaffold through a low-temperature rapid prototyping (LT-RP) 3D printing technology. The scaffold comprises a polyurethane (PU) matrix enhanced with bioactive manganese dioxide (MnO2) nanoparticles, combining structural integrity with versatile bioactivity for bone repair. By incorporating 2, 6-pyridinedimethanol (PDM) into the PU molecular network, a coordination system is formed, enabling homogeneous distribution and structural integration of MnO2 nanoparticles. As designed, the bioactive scaffolds are fabricated through LT-RP 3D printing technology with a regular porous architecture for improving cell growth. With 10 wt% MnO2, the scaffolds (PPM10) have optimal comprehensive properties, with a modulus of ~14.1 MPa, improved thermal stability, good cytocompatibility, and enhanced osteogenic differentiation. Furthermore, in vitro degradation tests revealed the responsive release of Mn2+ from the PPM10 scaffolds in a glutathione-rich microenvironment. This functionality indicates the potential of the scaffolds to modify the tumor microenvironment for ultimate bone regeneration after bone tumor surgery.

24 March 2026 in Materials
Verified
Journal Article
Open access
PDF file
CLCheng Lugano
Cheng Lugano
ZWZetao Wang
Zetao Wang
YLYujie Liu
Yujie Liu
YZYuyang Zhang
Yuyang Zhang
YGYu Gao
Yu Gao
Wei ZhangWei Zhang
Wei Zhang
Bone defects have become a leading cause of disability and mortality. The pro-inflammatory state and impaired vascularization are major factors hindering bone defect repair. However, current bone regeneration materials lack the ability to regulate the osteoimmune microenvironment and promote vascularized bone regeneration. In this study, we employed clinically used fat emulsion (FE), which is intravenously administered to provide nutrition and energy for patients, to investigate the effect of immunomodulation on promoting angiogenesis and osteogenesis. Results from RT-qPCR analysis and immunofluorescence staining demonstrated that FE exhibited potent anti-inflammatory effects by reducing the expression of the pro-inflammatory marker inducible nitric oxide synthase (iNOS) and upregulating the expression of the anti-inflammatory marker transforming growth factor-beta (TGF-β). Endothelial tube formation and scratch assays demonstrated that FE promoted angiogenesis and cell migration by releasing vascular endothelial growth factor (VEGF) within the inflammatory microenvironment. Alkaline phosphatase (ALP) and alizarin red S (ARS) staining revealed that FE facilitated ALP activity and calcium nodule formation by releasing bone morphogenetic protein-2 (BMP-2) within the inflammatory microenvironment. These findings may prove promising and cost-effective for the clinical treatment of bone defects.